Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma

Clinical trial NCT04895566 · COMPLETED

Trial details

NCT number: NCT04895566
Sponsor: SWISS BIOPHARMA MED GmbH
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pyoderma Pyoderma Gangrenosum Pyoderma Vegetans Pyoderma Gangrenosum Surrounding Surgical Stoma

Start date: 2021-05-24
Primary completion: 2023-03-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.